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INTRODUCTION 60
From the year 2000 until recently, the number of worldwide malaria cases had steadily fallen 61 mainly due to the widespread rollout of insecticide treated bed nets in endemic areas (1, 2), which 62 offer protection against bites from Plasmodium infected Anopheles mosquitoes. There is growing 63 evidence suggesting that the stalling in malaria control can be at least partially attributed to the 64 increasing levels of insecticide resistance in Anopheles vectors (3). Resistance in dominant 65
African Anopheles vectors has been recorded to all major insecticide classes currently used in 66 public health (pyrethroids, organochlorines, carbamates and organophosphates) (4). Therefore, 67 understanding the mechanisms by which mosquitoes evolve resistance is critical for the design of 68 mitigation strategies and in the evaluation of new classes of insecticides. 69
Research into the molecular mechanisms that give rise to resistance in mosquitoes have 70 identified target site modifications and increased metabolic detoxification as the two main 71 evolutionary adaptions (5), that often co-exist in An. gambiae. Families of detoxification enzymes, 72
including cytochromes P450 (CYP) and glutathione-S-transferases (GST), can provide phase I 73 metabolism of insecticides and phase II conjugation reactions that alter the toxicity of compounds 74 and increase polarity, enhancing excretion (6, 7). 75
To identify and characterise the role of the causative resistance genes from these detox families, 76 a sequential process of transcriptomic, proteomic and in vivo functional analysis is often applied 77 (8). Candidate genes with upregulated transcription or strong signatures of selection in resistant 78 mosquitoes are typically expressed in bacteria to provide evidence of insecticide depletion and/or 79 metabolism in vitro (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Further studies have used the Drosophila transgenic model to 80 determine whether expression of single Anopheles genes confers increased tolerance to 81 insecticides (13) (14) (15) (16) (17) (18) 20) . 82
This workflow has implicated a role in resistance of two cytochrome P450 genes, Cyp6m2 and 83 Cyp6p3, and a Glutathione S Transferase gene, Gste2, that are consistently upregulated in 84 resistant field populations found across Africa (21). However, there are often discrepancies in 85 results from recombinant protein activity and transgenic Drosophila analyses. For example, while 86 expression studies of Cyp6m2 and Cyp6p3 in E. coli (10, 11) and Drosophila (15) suggest that 87 both gene products can detoxify pyrethroids, the two systems produce conflicting results in 88 respect to carbamate (15) and organochlorine insecticide detoxification (12, 15, 19) . Moreover, 89 the involvement of An. gambiae and An. funestus Gste2 orthologues in resistance to pyrethroid 90 insecticides has produced contradictory results when explored in Drosophila (16, 20) . 91
Clearly, functional validation of Anopheles genes directly in the mosquito would provide the 92 benchmark approach to address these questions, however to date transgenic tools to perform 93 such analysis have been limited. To this end, we have developed the GAL4/UAS expression 94 5 system in An. gambiae (22) (23) (24) which allows genes to be overexpressed in a susceptible 95 mosquito background and for resultant resistance phenotypes to be examined using the standard 96 insecticide assays that have been developed for comparative analysis in mosquitoes by WHO 97 (25). 98
In vivo functional analysis in Anopheles can also help discover the mosquito tissues that are 99 specifically involved in insecticide metabolism. Our previous research indicated high P450 activity 100 in the midgut and oenocytes, since the essential P450 co-enzyme CPR is highly expressed in 101 these tissues, and RNAi knockdown of Cpr increased mosquito sensitivity to a pyrethroid 102 insecticide (26). Moreover, Cyp6m2 has been reported as enriched in the An. gambiae midgut 103 (11) and Cyp6p3 was found upregulated in midguts from pyrethroid resistant populations (27) . 104
Here we have used the GAL4/UAS system to overexpress Cyp6m2 or Cyp6p3 genes in multiple 105 tissues or specifically in the midgut or oenocytes of a susceptible An. gambiae strain and assayed 106 the modified mosquitoes against representatives of each insecticide class available for public 107 heath use. In doing so, we determined the resistance profile generated for each gene and 108 compared these results to those obtained in Drosophila and in vitro. We then analysed the other 109 major candidate, Gste2, to examine its role in conferring DDT resistance and also extending its 110 testing to other classes of insecticides in which its role has yet to be tested in vivo. 111
In this work, we report the first use of the GAL4/UAS system in Anopheles as a benchmark to 112 determine whether single candidate genes and/or expression in individual tissues are able to 113 confer WHO-defined levels of resistance to the four public health classes of insecticides, 114 including for the first time organophosphates. Crucially we find that, when assayed in An. 115 gambiae, overexpression of Cyp6m2, Cyp6p3 or Gste2 produce cross-resistance phenotypes 116 that encompass members of all four classes of insecticides currently used for malaria control. 117 6
RESULTS

118
Mosquito lines generated for UAS-regulated expression of Cyp6m2 and Cyp6p3
119 YFP marked UAS-Cyp6m2 and -Cyp6p3 lines were created by site directed recombination 120 mediated cassette exchange (RMCE) into a docking (CFP:2xattP) line A11 (24) to produce 121 mosquitoes carrying transgene insertions in the same genomic site. By mitigating for genomic 122 position effects, this allows more reliable comparison of the effects of Cyp6m2 and Cyp6p3 123 overexpression on resistance. 124 A summary of the screening and crossing strategy used to create the UAS responder lines is 125 illustrated in Table 1 . RMCE results in canonical cassette exchange in two potential orientations, 126 however integration of the whole donor transgene can also occur into either attP site. Fluorescent 127 marker screening of F1 progenies from F0 pooled mosquitoes revealed that cassette exchange 128 and integration events occurred in all experiments as shown by the recovery of individuals 129 carrying single (YFP: exchange) or double (CFP/YFP: integration) markers (Table 1) . 130
Molecular analysis revealed one exchange orientation (A) in transgenic UAS-m2 individuals and 131
both orientations for UAS-p3 transformation as indicated by diagnostic PCR (Fig. S1 ). Overall, we 132 found at least two events for UAS-m2 transformation, having equal efficiencies of 2% for 133 cassette-exchange and integration (1/49 F0 founders); while for the UAS-p3 transformation, at 134 least nine transformation events (six cassette exchanges, three in each orientation (A and B), and 135 three transgene integrations) were detected, with a minimum cassette-exchange efficiency of 5% 136 (6/124 F0) and integration efficiency of 2% (3/124 F0). For comparative functional analysis, 137
representative Cyp6 lines in orientation A were maintained and crossed with alternative GAL4 138 driver lines. 139 CYP6M2 or CYP6P3 overexpression in multiple tissues causes distinct profiles of 140 resistance to pyrethroids and bendiocarb 141 We previously described the production of a GAL4 driver line, Ubi-A10, directing widespread 142 tissue expression (23). To quantify the overexpression achieved with this driver, we performed 143 RT-qPCR in the progeny of Ubi-A10 driver and UAS-Cyp6 crosses. This revealed significant 144 2447x (P=0.005) and 513x (P<0.001) increases of Cyp6m2 and Cyp6p3 transcript abundance in 145 adult females compared to native expression in respective controls ( Fig. 1A) . Western analysis 146 also readily detected CYP6M2 in the adult female progeny of the Ubi-A10/UAS-m2 crosses, but 147 7 was beyond the level of detection in sibling controls (Ubi-A10/+ and +/UAS-m2) ( Fig. 1B) . No 148 suitable antiserum was available for analysis of CYP6P3. 149 WHO discriminating dose assays were then performed to assess the susceptibility of mosquitoes 150 overexpressing Cyp6m2 or Cyp6p3 compared to their Ubi-A10/+ siblings. WHO tube bioassays 151 are used to screen for the emergence of resistance in field populations and involve exposing 152 mosquitoes to fixed concentration of insecticides (twice the LC99 for a susceptible strain) for 60 153 minutes, followed by a twenty-four-hour recovery period before recording mortality (25). The 154 parental strains used here are susceptible (>90% mortality) to all the insecticides tested, 155 therefore a decrease in mortality in test assays can be directly attributable to the overexpression 156 of the specific candidate gene. 157
Mosquitoes overexpressing either Cyp6 gene under the Ubi-A10 driver showed resistance to 158 permethrin (Cyp6m2 28% mortality, P 0.001; Cyp6p3 43% mortality, P 0.001) and deltamethrin 159 (Cyp6m2 88%, P=0.04; Cyp6p3 52%, P=0.004) compared to controls (Fig. 1C) . A significant 160 difference in mortality was observed between mosquitoes overexpressing the two different Cyp6 161 genes for deltamethrin assays (P=0.003), while no significant difference was observed for 162 permethrin (P=0.15). However, only Cyp6p3 overexpressing mosquitoes showed resistance to 163 bendiocarb (13% mortality P 0.001) ( Fig. 1C ). No resistance to DDT was observed with either 164 gene in conjunction with the Ubi-A10 driver (Fig. 1C) . 165 CYP6M2 or CYP6P3 multi-tissue overexpression increases susceptibility to 166 malathion 167 Malathion is an organophosphate pro-insecticide that is activated to a more toxic compound in 168 vivo through P450-based oxidative reactions (28). Preliminary analysis at a standard WHO 169 diagnostic dose and 60-minute exposure killed all test and control mosquitoes, however during 170 exposure it was clear that Ubi-A10-directed Cyp6 overexpression induced more rapid knock-171 down compared to controls suggesting malathion activation by these P450s. We therefore 172 examined the relative sensitivity of mosquitoes overexpressing Cyp6m2 or Cyp6p3 when 173 exposed to the same diagnostic dose of this organophosphate for a shorter time (25 minutes) 174 ( Fig. 2 ). Under these conditions, mosquitoes overexpressing Cyp6m2 under the control of the 175 Ubi-A10 driver showed significantly higher mortality rates compared to controls (95% vs 15%, 176 P 0.001) and Ubi-A10/UAS-p3 mosquitoes (95% vs 34% P=0.002). Although, the latter also 177 showed a trend of increased mortality compared to Ubi-A10/+ controls (34% vs 8% P=0.05). in orientation A and one in orientation B (Fig. S1 ), and three integration events were 187 independently recovered with an overall transformation efficiency of 9% (6/65 F0), exchange 188 efficiency of 5% (3/65 F0), and integration efficiency of 5% (3/65 F0) (Table 1) . 189
To obtain comparable data for Gste2 and the Cyp6 genes, we focused our analysis on the 190 progeny from crosses between UAS-e2 and Ubi-A10GAL4 mosquitoes. When exposed to 191 diagnostic doses of DDT, GSTE2 overexpressing mosquitoes showed a significantly lower 192 mortality (7%, P<0.001) compared to controls, while no significant difference in resistance was 193 found when exposed to diagnostic doses of permethrin, deltamethrin, malathion or bendiocarb 194 we utilised previously published GAL4 driver lines to regulate tissue specific expression. The 206 specificity of these GAL4 drivers has been established following crosses with UAS regulated 207 fluorescent gene reporter lines (22, 24), but to examine the relative increase in tissue-specific 208
Cyp6 gene expression, we performed RT-qPCR and western blot analysis in progeny from 209 alternative driver and Cyp6 responder crosses. 210 9 Using the midgut driver (GAL4-mid), Cyp6m2 and Cyp6p3 transcripts were 2730x (P=0.002) and 211 659x (P=0.011) more abundant in midguts dissected from GAL4/UAS mosquitoes compared to 212 controls ( Fig. 4A) . A low level of overexpression was detected in the remaining carcass of 213 GAL4/UAS mosquitoes compared to that of controls (Cyp6m2: 77x, P=0.038; Cyp6p3: 7x, 214 P=0.08). In GAL4-oeno crosses, Cyp6m2 and Cyp6p3 were specifically upregulated in transgenic 215 dissected abdomens (66x, P=0.013 for Cyp6m2; 153x, P<0.001 for Cyp6p3) where oenocytes 216 are located (Fig. 4B ). Background overexpression was also found in the remaining carcass of 217 GAL4/UAS-m2 and -p3 adults compared to controls (26x, P<0.001; 2x, P<0.001 respectively). In 218 western blot analysis, CYP6M2 antiserum again only detected the target protein in GAL4/UAS 219 mosquitoes. CYP6M2 was found exclusively in dissected midguts (and whole mosquitoes) from 220 the progeny of GAL4-mid crosses, but was not observed in GAL4/UAS carcasses or extracts from 221 controls ( showed complete susceptibility to permethrin, deltamethrin, DDT, and bendiocarb. Similar results 226 were obtained with Cyp6p3 ( Fig. 4E and F), however potential resistance (95% mortality, 227 P=0.013) was suggested in oenocyte specific Cyp6p3 overexpressing mosquitoes when exposed 228 to permethrin (Fig. 4F ). Further analysis was performed to detect subtle differences in 229 susceptibility by repeating the assays with reduced exposure time ( Fig. S3 ). However, no 230 significant decrease (P<0.01) was found in the mortality rates of mosquitoes overexpressing 231
Cyp6m2 or Cyp6p3 in the midgut or oenocytes compared to their respective controls when 232 exposed for 20 minutes to the same diagnostic doses of the four insecticides ( Fig. S3 ). 233
Finally, the 25-minute reduced exposure bioassay for malathion showed no significant difference 234 in the mortality of mosquitoes overexpressing Cyp6m2 or Cyp6p3 in midgut or oenocytes 235 compared to controls ( Fig. S4 ). 236 10 DISCUSSION 237
In vivo functional analysis is critical to provide evidence of causative links between candidate 238 genes and their proposed phenotypes. Here we demonstrate the utility of new GAL4/UAS-based 239 tools to characterise gene function directly in An. gambiae by reporting the first use of the system 240 to validate the ability of single candidate genes to confer WHO-defined resistance to different 241 classes of insecticides. Overall, the transgenic analysis in An. gambiae is more in accordance 242 with data generated from recombinant protein studies of insecticide metabolism rather than those 243 obtained from Drosophila survival assays (Table 2) . 244
In Anopheles, multi-tissue overexpression of Cyp6m2 and Cyp6p3 demonstrated that resistance 245 to permethrin and deltamethrin (type I and II pyrethroids respectively) can be conferred by the 246 sole overexpression of either Cyp6 gene. Cyp6p3 expression also conferred resistance to 247 bendiocarb (carbamate); while the overexpression of either Cyp6 gene did not alter DDT 248 (organochlorine) sensitivity. These phenotypes correlate with the profile of metabolism or 249 substrate depletion of the respective insecticides for the two recombinant P450 enzymes (Table  250 2). More variable results have been observed using Drosophila as an in vivo model, with 251 overexpression of Cyp6m2 surprisingly generating increased tolerance to bendiocarb compared 252 with Cyp6p3, despite in vitro analysis not detecting activity against bendiocarb for Cyp6m2 (15, 253 19). DDT tolerance was also observed in Cyp6m2 overexpressing fruitflies, but data for Cyp6p3 254 could not be generated (15) ( Table 2) . In this study, DDT resistance was monitored by dose 255 response assays over a 24 hr exposure time, whilst bendiocarb resistance was not observed 256 when measured through such dose response assays but was reported following 24 hr exposure 257 to a diagnostic dose. In the latter case, the controls used to compare Cyp6m2 and Cyp6p3 258 overexpression showed very different levels of sensitivity to bendiocarb, which appeared to 259 contribute to the differences in resistance levels observed; whilst there was no data for the 260 respective Cyp6p3 controls in the DDT analysis for comparison. It may thus be a difference in 261 genetic background that gives rise to the discrepant results observed in Drosophila. However, it 262
should also be noted that the different methods of insecticide bioassay may not yield directly 263 comparable results to the diagnostic WHO level of resistance in mosquitoes used in this study 264 and extensively used to assess the emergence of resistance in endemic countries. Our data in 265 mosquitoes unequivocally indicate though that the expression of single Cyp6 genes can confer 266 resistance to different pyrethroids, and that Cyp6p3 overexpression confers cross resistance to 267 prominent representatives of at least two classes of public health insecticides. Although GSTs have been associated with organophosphate (OP) metabolism through 294 biochemical studies (7), we report the first evidence that the expression of a single gene can 295 provide OP resistance in mosquitoes. The high resistance shown towards fenitrothion by Gste2 296 overexpressing An. gambiae is intriguing. It is currently unclear if GSTE2 detoxifies fenitrothion by 297 sequestration, free radical protection or directly through conjugation/modification. Evidence from 298 early studies (31) suggest that Anopheles GST activity is associated with the conversion of 299 fenitrothion to the non-toxic metabolite desmethyl fenitrooxon through an oxidised intermediate. 300
Similar analysis in the Gste2 overexpressing lines would clarify which of these mechanisms is 301 involved. Further investigation is also needed on the OP malathion, for which we report 302 suspected resistance when Gste2 is overexpressed. 303
We have also demonstrated that Cyp6 overexpression increases susceptibility to malathion, as 304 well as conferring permethrin resistance, which may have direct implications on insecticide 305 management, especially if replicated with other OPs that may be used for Anopheles control (32). 306 Such sensitivity profiles are readily explained by the bio-activation of malathion to its more toxic 307 metabolite malaoxon (33) by a P450-mediated mechanism (28). Here we provide the first direct in 308 vivo evidence that CYP6 enzymes can confer negative cross resistance. Furthermore, there 309 appears to be substrate specificity in the alternative P450-mediated reactions, since we observed 310 higher mortality when assayed against Cyp6m2 overexpression compared to Cyp6p3. This may 311 suggest that Cyp6m2 favours the higher steady state production of the toxic intermediate 312
Malathion activation by Cyp6m2 is also supported by recent evidence provided by Ingham et al 314 (34) who found that knock down of the transcription factor Maf-S results in increased survival 315 following malathion exposure. One of the P450s downregulated by Maf-S knockdown was 316 Cyp6m2, whereas Cyp6p3 transcription was not modified. Taken together, the results provide 317 experimental evidence to support the use of OPs, and potentially other pro-insecticides activated 318 by CYP6 enzymes, for Anopheles control in areas where pyrethroid resistance is also conferred 319 by detoxification by the same enzyme/s. One such strategy involves combining the use of 320 pyrethroid-based bed nets with OP-based residual wall spraying or impregnated hangings (32). 321
This takes advantage of the additive effect of the two classes of insecticides, while sensitising 322
Cyp6-based pyrethroid resistant mosquitoes to malathion (35). In conjunction with recombinant 323 enzyme assays, the modified mosquitoes described may thus become valuable tools to assess 324 the susceptibility of new public health pro-insecticides, for example chlorfenapyr (36), to activation 325 and detoxification by xenobiotic metabolising P450 genes in Anopheles. 326
When validating resistance phenotypes conferred by transgenic overexpression, the spatial 327 pattern of overexpression can give clues to the identity of key tissues of detoxification. The 328 expression driven by Ubi-A10 is spread over multiple tissues, which makes it impossible to 329 pinpoint which tissue/s are particularly important for generating the resistance phenotype. Here, 330 we directly investigated the involvement of the midgut and oenocytes in conferring P450-331 mediated resistance. Critically, we did not observe clear resistance to any insecticide class when 332 either Cyp6m2 or Cyp6p3 were specifically expressed in either of these tissues, despite achieving 333 highly enriched expression and the knowledge that oenocytes and the midgut express abundant 334 P450 co-enzyme CPR (26). Furthermore, since our previous expression profiling of the Ubi-A10 335 driver indicated lack of expression in Malpighian tubules (23) yet resistance to multiple 336 insecticides was observed with this driver, it would appear that the insecticides tested are not 337 predominately metabolised in the Malpighian tubules either, and other unidentified tissues may be 338 critical, alone or in combination, for detoxification. As described earlier, some evidence of tissue 339 specificity of P450s associated with insecticide resistance has been derived from transcriptomic 340 analysis of crude dissections of tissues and body segments from pyrethroid resistant and 341 sensitive strains (27). This study indicated that Cyp6p3 is more highly expressed in the midgut of 342 the resistant strain, whereas Cyp6m2 has a broader upregulation in midgut, Malpighian tubules 343 13 and the abdomen (integument, fat body and ovaries). The relevance of elevated Cyp6p3 levels in 344 the midgut of the examined resistant strain is difficult to reconcile with the lack of a resistance 345 phenotype when the same gene is overexpressed in this tissue with the GAL4/UAS system. 346
Previous Drosophila studies have shown that overexpression using drivers active in multiple 347 tissues, such as actin5C-GAL4 (14) (15) (16) (17) (18) Similarly, it is possible to use the integration line carrying both Ubi-GAL4 and UAS-Gste2 to cross 366 with other UAS-detox genes to analyse metabolic interactions, for example combining phase I 367 and II metabolism. In addition, the Ubi-A10 driver is active in larval stages (23) and can thus be 368 used to examine gene function in immature stages. 369 Importantly, for future work, there is growing evidence on the involvement in resistance of genes 370 that are very difficult to test in vitro due to the lack of appropriate assays. These include genes 371 coding for cuticle components (39), transcription factors (34) and other binding proteins, e.g. 372 hexamerins and α-crystallins (21), for which current transgenic tools, including GAL4/UAS, make 373
An. gambiae the most relevant option for functional genetic analysis. Cyp6m2 (1500 bp), derived from the susceptible strain Kisumu, was amplified from 380 PB13:CYP6M2 (11) using primers M2fw and M2rv (Table S1 ). The coding sequence of Cyp6p3 381 was obtained by amplifying a 193 bp fragment from Kisumu cDNA using primers P3fw1 and 382
P3rv1 (Table S1 ) and a 1362 bp fragment from pCW:17α-Cyp6p3 (10) using primers P3fw2 and 383
P3rv2 (Table S1 ). P3fw1 and P3rv2 were then used to join the two fragments and obtain the 1530 384 bp full length Cyp6p3 coding sequence. The 666 bp Gste2-114T coding sequence derived from 385 the DDT-resistant strain ZAN/U was amplified from the K1B plasmid (13) using primers 386
Gste2k1bfor and Gste2k1brev (Table S1 ). All coding sequences were cloned into the YFP-387 marked responder plasmid pSL*attB:YFP:Gyp:UAS14i:Gyp:attB (24) downstream of the UAS 388 using EcoRV/XhoI (Cyp6) or EcoRI/NcoI (Gste2). 389 (Table S1 ). The qP3sub primer bears a nucleotide substitution (A11G) to conform its sequence to 426 that of the G3 strain template. Two housekeeping genes, the ribosomal protein S7 (RPS7) 427 (AGAP010592) and ribosomal protein L40/Ubiquitin (AGAP007927), were also quantified using 428 primers qS7fw, qS7rv, qUBfw and qUBrv (42) ( Table S1 ). Transcription data obtained by RT-429 qPCR were analysed using the ΔΔCt method as described in SI. Gene expression analysis was 430 not performed to assess upregulation of the Gste2 transcript. 431
Creation of UAS responder lines by PhiC31-mediated cassette exchange
CYP6 and GSTE2 protein expression analysis 432
To detect protein expression in GAL4/UAS and GAL4/+ individuals, total protein extracts were 433 obtained from whole 2-5-day-old female adults and their dissected body parts. Protein extracts 434 16 equivalent to 1/3 of a mosquito or its body part were analysed to detect CYP6 expression driven 435 by tissue-specific drivers. With the exception of midgut samples, for which two whole midguts 436 were analysed. The higher amount of midgut sample was required to visualise signal of the α-437 tubulin loading control. The equivalent of 1/10 of a single female mosquito was used to assess 438 expression driven by ubiquitous drivers. CYP6s were probed using primary affinity-purified 439 polyclonal peptide antibodies produced in rabbit against CYP6M2 or CYP6P3 (gifts from Dr M. 440 Paine), while GSTE2 was probed with anti-GSTE2-28 rabbit primary antibodies (9). Secondary 441 antibodies were anti-rabbit-HRP IgGs (Bethyl Laboratories). Detection of the loading control α-442 tubulin was performed using primary mouse anti-αtubulin antibodies (Sigma or Fisher Scientific) 443 and secondary goat anti-mouse-HRP IgG antibodies (Abcam). Signal detection was carried out 444
using SuperSignal™ West Dura Extended Duration Substrate (Life Technologies). 445
Assessment of susceptibility to insecticides 446
Susceptibility to insecticides was assessed in mosquitoes overexpressing Cyp6 genes using the 447 WHO tube bioassay (25). Pools of 20-25 GAL4/UAS and GAL4/+ adult female mosquitoes were 448 exposed 2-5 days post-emergence to standard discriminating doses of insecticides -0.75% 449 permethrin, 0.05% deltamethrin, 0.1% bendiocarb, 4% DDT -for 60 minutes and mortality rates 450 assessed after a 24 hour recovery period. For mosquitoes expressing Cyp6 genes in the midgut 451 or oenocytes a modified version of the standard WHO test was also performed reducing the 452 exposure time to 20 minutes (26). For assessing susceptibility to 5% malathion in mosquitoes 453 overexpressing Cyp6 genes, the exposure time was decreased to 25 minutes. Mosquitoes 454 overexpressing Gste2 were additionally tested for 1% fenitrothion using the recommended 2 h 455 exposure time. 1-4 biological replicates were performed for each insecticide tested. A total of 2-8 456 technical replicate tubes were tested for each population. Welch's t-test was performed to 457 determine statistical differences between mortality rates in GAL4/UAS and GAL4/+. Details on 458 statistical analysis and replicate numbers of bioassay experiments are reported in Table S2 . 459 Table  599 S2). Welch's t test with P<0.01 significance cut off, *** P<0.001. Table S2 ). 604
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